Eric Lancelot
Overview
Explore the profile of Eric Lancelot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shahid I, Lancelot E
Invest Radiol
. 2025 Feb;
PMID: 39951051
Objective: Some patients who received multiple administrations of gadolinium-based contrast agents (GBCAs) have been reported to develop "symptoms associated with gadolinium exposure" (SAGE). The aim of this study was to...
2.
Spinazzi A, Lancelot E, Vitali L, Cot C, Pirovano G, Joseph A, et al.
Invest Radiol
. 2024 Dec;
PMID: 39692431
Gadopiclenol is a novel, macrocyclic high-relaxivity gadolinium-based contrast agent recently approved for use in magnetic resonance imaging of the central nervous system and body organs at a dose of 0.05...
3.
Shahid I, Joseph A, Lancelot E
Invest Radiol
. 2022 Apr;
57(10):664-673.
PMID: 35471204
Objective: Recent scientific publications have reported cases of patients who complained from a variety of symptoms after they received a gadolinium-based contrast agent (GBCA). The aim of this study was...
4.
Laissy J, Siauve N, Dossier A, Lancelot E
J Magn Reson Imaging
. 2021 Mar;
54(2):669-671.
PMID: 33768662
No abstract available.
5.
Lancelot E, Raynaud J, Desche P
Invest Radiol
. 2020 Aug;
55(9):578-588.
PMID: 32776767
This review summarizes 30 years of experience in the development and clinical use of magnetic resonance (MR) contrast agents. Despite their undisputable usefulness for disease diagnosis, gadolinium (Gd)-based contrast agents...
6.
Shahid I, Lancelot E, Desche P
Invest Radiol
. 2020 May;
55(9):598-600.
PMID: 32452883
Iodinated contrast media (CM) are utilized in approximately 40% of the 300 million computed tomography (CT) scans undertaken annually. This review focuses on the physicochemical properties and safety of iodinated...
7.
Lancelot E, Desche P
Invest Radiol
. 2019 Nov;
55(1):20-24.
PMID: 31725063
Objectives: The purpose of this manuscript is to review the successive regulatory actions and decisions following the initial publication by Kanda and colleagues in 2014 regarding gadolinium retention in the...
8.
Desche P, Piednoir B, Lancelot E
Radiology
. 2019 Sep;
293(2):481-482.
PMID: 31502934
No abstract available.
9.
Raynaud J, Darmon-Kern E, Lancelot E, Laurent A, Desche P
Radiol Med
. 2018 Feb;
123(6):432-433.
PMID: 29476438
No abstract available.
10.
Raynaud J, Darmon-Kern E, Lancelot E, Desche P
Radiology
. 2018 Feb;
286(3):1094-1095.
PMID: 29461950
No abstract available.